Dr. Frye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1919 E Thomas Rd
Phoenix, AZ 85016Phone+1 602-933-0970Fax+1 602-933-4253
Education & Training
- Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 2000 - 2003
- University of Miami/Jackson Health SystemResidency, Pediatrics, 1998 - 2000
- Georgetown University School of MedicineClass of 1998
Certifications & Licensure
- AZ State Medical License 2017 - 2025
- CA State Medical License 2023 - 2025
- FL State Medical License 2005 - 2025
- KY State Medical License 2018 - 2019
- AR State Medical License 2011 - 2018
- TX State Medical License 2007 - 2017
- MA State Medical License 2003 - 2005
- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders Start of enrollment: 2010 Jul 01
- A Folinic Acid Intervention for Autism Spectrum Disorders Start of enrollment: 2012 May 01
- Mitochondrial Dysfunction in Phelan-McDermid Syndrome Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- 33 citationsCerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Ana...Daniel A. Rossignol, Richard E. Frye
Journal of Personalized Medicine. 2021-11-03 - 55 citationsFolate metabolism abnormalities in autism: potential biomarkers.Richard E. Frye, John Slattery, Edward V. Quadros
Biomarkers in Medicine. 2017-08-03 - 8 citationsA Personalized Multidisciplinary Approach to Evaluating and Treating Autism Spectrum Disorder.Richard E Frye
Journal of Personalized Medicine. 2022-03-14
Press Mentions
- Stealth’s Phase III Elamipretide in Mitochondrial Myopathy Has Experts Wary While FDA Approval DebatedJune 17th, 2019
- Phoenix Children’s Earns $1 Million in Grants for Autism ResearchJanuary 12th, 2019
- Neurologist Andrew Zimmerman Fired by DOJ for Change of OpinionJanuary 9th, 2019
- Join now to see all
Grant Support
- Developmental Phonological Dyslexia: Neural MechanismsNational Institute Of Neurological Disorders And Stroke2006–2009
- Developmental Phonological Dyslexia: Neural MechanismsNational Institute Of Neurological Disorders And Stroke2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: